Literature DB >> 31127412

Community Screening, Identification, and Referral to Primary Care, for Hepatitis C, B, and HIV Among Homeless Persons in Los Angeles.

Daniel Fuster1, Lillian Gelberg2,3.   

Abstract

People experiencing homelessness are disproportionally affected by drug and alcohol use and by their serious health consequences. In this study, 137 adults from the "UCLA/ARG/RAND Homeless Hepatitis Study" who were sampled from shelters and meal programs in the Skid Row of Los Angeles and screened for HIV or HCV or HBV infection. Those who tested positive for these infections were counseled about their infections and referred to primary care. They were followed-up at 1 month with interviews to identify rates, and predictors, of seeking primary care. Participants were 87.5% male, mean age of 48.6 years (SD: 8.2); most were Black (77.4%) and were chronically homeless (> 12 months). A majority (70%) had a regular source of care; 78% were lifetime marijuana users, 56% were lifetime cocaine users and 51% had injected intravenously during the past year. Among this sample, 118 participants (86.1%) tested seropositive for HCV infection, 79 (57.7%) HBV infection and 18 (13.1%) HIV infection. At 1-month follow-up, 102 participants (74.5%) attended the clinic they were referred to. The only variable associated with attending the clinic was having slept in a shelter during the previous night versus other sleeping conditions [Odds ratio (95% CI): 3 .0 (1.07-8.42), p = 0.03]. This model offers a simple and efficacious approach to seeking, testing, counseling, and referral to treatment of community-based adults experiencing homelessness with HIV, HCV and/or HBV infection and linking them to primary care. Being sheltered may be the key facilitator for homeless seeking primary care.

Entities:  

Keywords:  HBV; HCV; HIV; Homeless

Mesh:

Year:  2019        PMID: 31127412     DOI: 10.1007/s10900-019-00679-w

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  31 in total

Review 1.  Health interventions for people who are homeless.

Authors:  Stephen W Hwang; Tom Burns
Journal:  Lancet       Date:  2014-10-25       Impact factor: 79.321

2.  Outcomes of treatment for hepatitis C virus infection by primary care providers.

Authors:  Sanjeev Arora; Karla Thornton; Glen Murata; Paulina Deming; Summers Kalishman; Denise Dion; Brooke Parish; Thomas Burke; Wesley Pak; Jeffrey Dunkelberg; Martin Kistin; John Brown; Steven Jenkusky; Miriam Komaromy; Clifford Qualls
Journal:  N Engl J Med       Date:  2011-06-01       Impact factor: 91.245

3.  HIV seroprevalence among homeless and marginally housed adults in San Francisco.

Authors:  Marjorie J Robertson; Richard A Clark; Edwin D Charlebois; Jacqueline Tulsky; Heather L Long; David R Bangsberg; Andrew R Moss
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

4.  What's the agreement between self-reported and biochemical verification of drug use? A look at permanent supportive housing residents.

Authors:  Alexis Rendon; Melvin Livingston; Sumihiro Suzuki; Whitney Hill; Scott Walters
Journal:  Addict Behav       Date:  2017-02-10       Impact factor: 3.913

5.  HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities.

Authors:  A H Kral; R N Bluthenthal; R E Booth; J K Watters
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

6.  Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons.

Authors:  Vanessa V Thompson; Kathleen E Ragland; Christopher S Hall; Maureen Morgan; David R Bangsberg
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

7.  Factors associated with access to care and healthcare utilization in the homeless population of England.

Authors:  Tim Elwell-Sutton; Jonathan Fok; Francesca Albanese; Helen Mathie; Richard Holland
Journal:  J Public Health (Oxf)       Date:  2017-03-01       Impact factor: 2.341

8.  A unique model for treating chronic hepatitis C in patients with psychiatric disorders, substance abuse, and/or housing instability.

Authors:  Cheryl J Ho; Charles Preston; Kim Fredericks; Sara L Doorley; Richard J Kramer; Lawrence Kwan; Ahmad Kamal
Journal:  J Addict Med       Date:  2013 Sep-Oct       Impact factor: 3.702

9.  Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.

Authors:  Jason Grebely; Maryam Alavi; Michelle Micallef; Adrian J Dunlop; Anne C Balcomb; Nghi Phung; Martin D Weltman; Carolyn A Day; Carla Treloar; Nicky Bath; Paul S Haber; Gregory J Dore
Journal:  Addiction       Date:  2015-11-25       Impact factor: 6.526

Review 10.  The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.

Authors:  N H Afdhal; S Zeuzem; R T Schooley; D L Thomas; J W Ward; A H Litwin; H Razavi; L Castera; T Poynard; A Muir; S H Mehta; L Dee; C Graham; D R Church; A H Talal; M S Sulkowski; I M Jacobson
Journal:  J Viral Hepat       Date:  2013-11       Impact factor: 3.728

View more
  6 in total

1.  Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective.

Authors:  J Konadu Fokuo; Carmen L Masson; August Anderson; Jesse Powell; Dylan Bush; Margaret Ricco; Barry Zevin; Claudia Ayala; Mandana Khalili
Journal:  Hepatol Commun       Date:  2020-03-03

2.  Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.

Authors:  Carmen L Masson; J Konadu Fokuo; August Anderson; Jesse Powell; Barry Zevin; Dylan Bush; Mandana Khalili
Journal:  BMC Infect Dis       Date:  2020-05-29       Impact factor: 3.090

3.  Identifying Missed Opportunities for Routine Vaccination among People Who Use Drugs.

Authors:  Paula M Frew; Jay T Schamel; Laura A Randall; Adrian R King; Ian W Holloway; Katherine Burris; Anne C Spaulding
Journal:  Int J Environ Res Public Health       Date:  2021-02-04       Impact factor: 3.390

4.  Formal Hepatitis C Education Increases Willingness to Receive Therapy in an On-site Shelter-Based HCV Model of Care in Persons Experiencing Homelessness.

Authors:  Diana Partida; Jesse Powell; Margaret Ricco; Jessica Naugle; Catherine Magee; Barry Zevin; Carmen L Masson; J Konadu Fokuo; Daniel Gonzalez; Mandana Khalili
Journal:  Open Forum Infect Dis       Date:  2022-03-01       Impact factor: 3.835

5.  A qualitative investigation of organizational challenges and facilitators to screening individuals experiencing homelessness for hepatitis C virus (HCV) in Houston, Texas.

Authors:  Alane Celeste-Villalvir; J Michael Wilkerson; Christine Markham; Lourdes Rodriguez; Vanessa Schick
Journal:  PLoS One       Date:  2022-08-22       Impact factor: 3.752

6.  Viral blood-borne infections testing and linkage to care cascade among persons who experience homelessness in the United States: a systematic review and meta-analysis.

Authors:  Ria Saha; Amanda P Miller; Andrea Parriott; Hacsi Horvath; James G Kahn; Mohsen Malekinejad
Journal:  BMC Public Health       Date:  2022-07-26       Impact factor: 4.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.